An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and Peptides After Peptide Sciences Renew Vitality RFK Jr. and the Perils of Peptides Washington Monthly The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York